A. L. K. et al v. Johnson & Johnson et al
| A. L. K. and A. M. K. |
| Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco, McKesson Corporation, Cardinal Health, Inc., H.D. Smith, LLC, H.D. Smith Holdings, LLC, H.D. Smith Holding Comp, AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, Anda, Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Allergan USA, Inc., Allergan Sales LLC, Allergan PLC, Allergan Finance LLC, AbbVie Inc., McKinsey & Company, Inc., McKinsey & Company, Inc. United States, McKinsey & Company, Inc. Washington D.C. and West Virginia Board of Pharmacy |
| 2:2022cv00474 |
| October 26, 2022 |
| US District Court for the Southern District of West Virginia |
| David A Faber |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-Personal Injury |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 17, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 44
STATEMENT OF VISITING ATTORNEY from Kathleen L. Matsoukas on behalf of H.D. Smith, LLC, H.D. Smith Holding Comp, H.D. Smith Holdings, LLC. Local counsel: Todd A. Mount. Fee $50.00. Receipt # AWVSDC-8332104. (Mount, Todd)
|
|
Filing 43
STATEMENT OF VISITING ATTORNEY from William E. Padgett on behalf of H.D. Smith, LLC, H.D. Smith Holding Comp, H.D. Smith Holdings, LLC. Local counsel: Todd A. Mount. Fee $50.00. Receipt # AWVSDC-8332021. (Mount, Todd)
|
|
Filing 42
NOTICE OF APPEARANCE by Tim J. Yianne, Patricia M. Bello and Sophie L. Johns on behalf of AbbVie Inc. (Bello, Patricia)
|
|
Filing 41
NOTICE OF APPEARANCE by Tim J. Yianne, Patricia M. Bello and Sophie L. Johns on behalf of Allergan Finance LLC, Allergan Sales LLC, Allergan USA, Inc. (Bello, Patricia)
|
|
Filing 40
NOTICE OF APPEARANCE by Melissa Foster Bird on behalf of Janssen Pharmaceuticals, Inc., Johnson & Johnson. (Bird, Melissa)
|
|
Filing 39
REPLY MEMORANDUM by H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC to #37 Memorandum In Opposition. (Mount, Todd) (Modified on 12/12/2022 to remove link to #33 motion and #34 memorandum) (kew).
|
|
Filing 38
MOTION HEARING held by Senior Judge David A. Faber on 12/8/2022 re: #9 EMERGENCY MOTION by A. L. K., A. M. K. to Remand and to Expedite Resolution of the Motion to Remand Court Reporter: Lisa Cook. (cel)
|
|
Filing 37
MEMORANDUM by A. L. K., A. M. K. in opposition to #33 MOTION by H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC to Dismiss Complaint (McLaughlin, Alexander)
|
|
Filing 36
REPLY MEMORANDUM by AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, Cardinal Health, Inc., McKesson Corporation to #18 Response Memorandum In Opposition. (Hester, Timothy) (Modified on 11/28/2022 to correct link) (kew).
|
|
Filing 35
REPLY MEMORANDUM by A. L. K., A. M. K. to #31 Memorandum In Opposition. (Attachment: #1 Exhibit 2)(McLaughlin, Alexander)
|
|
Filing 34
MEMORANDUM by H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC in support of #33 MOTION by H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC to Dismiss Complaint. (Mount, Todd)
|
|
Filing 33
MOTION by H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC to Dismiss Complaint Attached to #1 Notice of Removal. (Mount, Todd) (Modified on 11/21/2022 to add link to #1 notice of removal) (kew).
|
|
Filing 32
RESPONSE MEMORANDUM by A. L. K., A. M. K. in opposition to #18 MOTION by McKesson Corporation, AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, Cardinal Health, Inc. to Dismiss Complaint. (Attachment: #1 Exhibit 1)(McLaughlin, Alexander) (Modified on 11/17/2022 to add party filer) (kew).
|
|
Filing 31
MEMORANDUM by AbbVie Inc., Allergan Finance LLC, Allergan Sales LLC, Allergan USA, Inc., AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, Anda, Inc., Cardinal Health, Inc., H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKesson Corporation, McKinsey & Company, Inc., McKinsey & Company, Inc. United States, McKinsey & Company, Inc. Washington D.C., Noramco, Teva Pharmaceuticals USA, Inc. in opposition to #9 EMERGENCY MOTION by A. L. K., A. M. K. to Remand and to Expedite Resolution of the Motion to Remand (Hester, Timothy)
|
|
Filing 30
NOTICE OF APPEARANCE by Justin C. Taylor, Michael W. Taylor on behalf of West Virginia Board of Pharmacy. (Taylor, Justin)
|
|
Filing 29
ORDER granting the #25 REQUEST by A. L. K., A. M. K. for Oral Argument on #9 EMERGENCY MOTION by A. L. K., A. M. K. to Remand and to Expedite Resolution of the Motion to Remand; a Hearing is set for 12/8/2022 at 10:00 AM in Charleston before Senior Judge David A. Faber. Signed by Senior Judge David A. Faber on 11/7/2022. (cc: counsel of record) (lca)
|
|
Filing 28
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendants H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC (Mount, Todd)
|
|
Filing 27
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant Cardinal Health, Inc. (Ruby, Steven)
|
|
Filing 26
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendants Janssen Pharmaceuticals, Inc., Johnson & Johnson (Williams, Marc)
|
|
Filing 25
REQUEST by A. L. K., A. M. K. for Oral Argument on #9 EMERGENCY MOTION by A. L. K., A. M. K. to Remand and to Expedite Resolution of the Motion to Remand. (Goodwin, R.) (Modified on 11/3/2022 to convert event to motion) (kew).
|
|
SET ANSWER DEADLINES for AbbVie Inc., Allergan Finance LLC, Allergan Sales LLC, Allergan USA, Inc., Anda, Inc., H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Noramco, Teva Pharmaceuticals USA, Inc., West Virginia Board of Pharmacy to 1/27/2023. (kew)
|
|
Filing 24
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant Anda, Inc. (Jones, Keith)
|
|
Filing 23
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant Teva Pharmaceuticals USA, Inc. (Jones, Keith)
|
|
Filing 22
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendants AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation (Callas, Gretchen)
|
|
Filing 21
STIPULATION EXTENDING TIME AND ACCEPTING SERVICE re: Complaint Attached to #1 Notice of Removal to 1/27/2023 by Janssen Pharmaceuticals, Inc., Johnson & Johnson, Noramco, H.D. Smith, LLC, H.D. Smith Holdings, LLC, H.D. Smith Holding Comp, Anda, Inc., Teva Pharmaceuticals USA, Inc., Allergan USA, Inc., Allergan Sales LLC, Allergan Finance LLC, AbbVie Inc., West Virginia Board of Pharmacy, A. L. K., A. M. K. (Williams, Marc) (Modified on 11/3/2022 to add party filers) (kew).
|
|
Filing 20
NOTICE OF APPEARANCE by Steven R. Ruby, Raymond S. Franks II, David R. Pogue on behalf of Cardinal Health, Inc. (Ruby, Steven)
|
|
Filing 19
MEMORANDUM by McKesson Corporation, AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, Cardinal Health, Inc. in support of #18 MOTION by McKesson Corporation, AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, Cardinal Health, Inc. to Dismiss Complaint. (Wakefield, Jeffrey) (Modified on 11/3/2022 to add party filers) (kew).
|
|
Filing 18
MOTION by McKesson Corporation, AmerisourceBergen Corporation, AmerisourceBergen Drug Corporation, Cardinal Health, Inc. to Dismiss Complaint Attached to #1 Notice of Removal. (Attachments: #1 Exhibit 1, #2 Exhibit 2) (Wakefield, Jeffrey) (Modified on 11/3/2022 to add link to #1 notice of removal and to add party filers) (kew).
|
|
Filing 17
STATEMENT OF VISITING ATTORNEY from Timothy C. Hester on behalf of McKesson Corporation. Local counsel: Jeffrey M. Wakefield. Fee $50.00. Receipt # AWVSDC-8301739. (Wakefield, Jeffrey)
|
|
Filing 16
NOTICE OF APPEARANCE by Kelly Calder Mowen, Jon B. Orndorff on behalf of Noramco. (Mowen, Kelly)
|
|
Filing 15
EMERGENCY MOTION by Janssen Pharmaceuticals, Inc., Johnson & Johnson for Extension of Time to File Responsive Pleading to Complaint Attached to #1 Notice of Removal. (Williams, Marc)
|
|
Filing 14
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant McKesson Corporation (Wakefield, Jeffrey)
|
|
Filing 13
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant Noramco (Mowen, Kelly)
|
|
Filing 12
NOTICE OF APPEARANCE by Marc E. Williams, Robert L. Massie on behalf of Janssen Pharmaceuticals, Inc., Johnson & Johnson. (Williams, Marc)
|
|
Filing 11
NOTICE OF CHANGE OF ATTORNEY INFORMATION by Stephanie Holbrook Daly appearing on behalf of A. L. K., A. M. K. (Daly, Stephanie)
|
|
Filing 10
MEMORANDUM OF LAW by A. L. K., A. M. K. in support of #9 EMERGENCY MOTION by A. L. K., A. M. K. to Remand and to Expedite Resolution of the Motion to Remand. (Goodwin, R.) (Modified on 10/31/2022 to add party filer) (kew).
|
|
Filing 9
EMERGENCY MOTION by A. L. K., A. M. K. to Remand and to Expedite Resolution of the Motion to Remand. (Attachment: #1 Exhibit 1)(Goodwin, R.) (Modified on 10/31/2022 to add party filer) (kew).
|
|
SET ANSWER DEADLINES for McKinsey & Company, Inc., McKinsey & Company, Inc. United States, McKinsey & Company, Inc. Washington D.C. to 1/27/2023. (kew)
|
|
Filing 8
CLERK'S ORDER. For reasons appearing to the court, the referral of this civil action for discovery matters is assigned to the Magistrate Judge Omar J. Aboulhosn. Signed by Clerk of Court Rory L. Perry II on 10/27/2022. (cc: counsel of record; any unrepresented party) (klc)
|
|
Filing 7
STIPULATION EXTENDING TIME to respond to the Complaint Attached to #1 Notice of Removal to 1/27/2023 by McKinsey & Company, Inc., McKinsey & Company, Inc. United States, McKinsey & Company, Inc. Washington D.C., A. M. K., A. L. K. (George, Keith) (Modified on 10/28/2022 to add link to #1 notice of removal and to add party filers) (kew).
|
|
Filing 6
NOTICE OF APPEARANCE by Todd A. Mount on behalf of H.D. Smith Holding Comp, H.D. Smith Holdings, LLC, H.D. Smith, LLC. (Mount, Todd)
|
|
Filing 5
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant McKinsey & Company, Inc. Washington D.C. (George, Keith)
|
|
Filing 4
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant McKinsey & Company, Inc. United States (George, Keith)
|
|
Filing 3
DISCLOSURE STATEMENT PURSUANT TO RULE 7.1, Federal Rules of Civil Procedure, by Defendant McKinsey & Company, Inc. (George, Keith)
|
|
CASE assigned to Senior Judge David A. Faber. (klc)
|
|
Filing 2
NOTICE OF APPEARANCE by Keith J. George, John C. Palmer IV, David S. Russo, W. Bradley Sorrells on behalf of McKinsey & Company, Inc., McKinsey & Company, Inc. United States, McKinsey & Company, Inc. Washington D.C. (George, Keith)
|
|
Filing 1
NOTICE OF REMOVAL by AmerisourceBergen Drug Corporation with summons, complaint, docket sheet and other miscellaneous documents from Circuit Courts of Marshall and Kanawha County. Filing Fee $402.00. Receipt #AWVSDC-8295948. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 State Court File, #4 Civil Cover Sheet) (mk)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
